Global Hormonal Contraceptive Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Hormonal Contraceptive Market Overview

• 1.1 Product Overview and Scope of Hormonal Contraceptive
• 1.2 Classification of Hormonal Contraceptive by Type
  • 1.2.1 Global Hormonal Contraceptive Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Hormonal Contraceptive Revenue Market Share by Type in 2019
  • 1.2.3 Oral Contraceptive Pills
  • 1.2.4 Injectable Birth Control
  • 1.2.5 Emergency Contraceptive Pills
  • 1.2.6 Vaginal Rings
  • 1.2.7 Transdermal Patches
• 1.3 Global Hormonal Contraceptive Market by Application
  • 1.3.1 Overview: Global Hormonal Contraceptive Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Hospitals
  • 1.3.3 Household
  • 1.3.4 Clinics
• 1.4 Global Hormonal Contraceptive Market by Regions
  • 1.4.1 Global Hormonal Contraceptive Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Hormonal Contraceptive (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Hormonal Contraceptive Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Hormonal Contraceptive Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hormonal Contraceptive Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Hormonal Contraceptive Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hormonal Contraceptive Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Ansell Limited
  • 2.1.1 Ansell Limited Details
  • 2.1.2 Ansell Limited Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Ansell Limited SWOT Analysis
  • 2.1.4 Ansell Limited Product and Services
  • 2.1.5 Ansell Limited Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Pfizer
  • 2.2.1 Pfizer Details
  • 2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Pfizer SWOT Analysis
  • 2.2.4 Pfizer Product and Services
  • 2.2.5 Pfizer Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Johnson and Johnson
  • 2.3.1 Johnson and Johnson Details
  • 2.3.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Johnson and Johnson SWOT Analysis
  • 2.3.4 Johnson and Johnson Product and Services
  • 2.3.5 Johnson and Johnson Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Bayer AG
  • 2.4.1 Bayer AG Details
  • 2.4.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Bayer AG SWOT Analysis
  • 2.4.4 Bayer AG Product and Services
  • 2.4.5 Bayer AG Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Mylan N.V.
  • 2.5.1 Mylan N.V. Details
  • 2.5.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Mylan N.V. SWOT Analysis
  • 2.5.4 Mylan N.V. Product and Services
  • 2.5.5 Mylan N.V. Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Church and Dwight Co
  • 2.6.1 Church and Dwight Co Details
  • 2.6.2 Church and Dwight Co Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Church and Dwight Co SWOT Analysis
  • 2.6.4 Church and Dwight Co Product and Services
  • 2.6.5 Church and Dwight Co Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 The Female Health Company
  • 2.7.1 The Female Health Company Details
  • 2.7.2 The Female Health Company Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 The Female Health Company SWOT Analysis
  • 2.7.4 The Female Health Company Product and Services
  • 2.7.5 The Female Health Company Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Merck and Co
  • 2.8.1 Merck and Co Details
  • 2.8.2 Merck and Co Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Merck and Co SWOT Analysis
  • 2.8.4 Merck and Co Product and Services
  • 2.8.5 Merck and Co Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Mayer Laboratories
  • 2.9.1 Mayer Laboratories Details
  • 2.9.2 Mayer Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Mayer Laboratories SWOT Analysis
  • 2.9.4 Mayer Laboratories Product and Services
  • 2.9.5 Mayer Laboratories Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Teva Pharmaceutical Industries
  • 2.10.1 Teva Pharmaceutical Industries Details
  • 2.10.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Teva Pharmaceutical Industries SWOT Analysis
  • 2.10.4 Teva Pharmaceutical Industries Product and Services
  • 2.10.5 Teva Pharmaceutical Industries Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Organon International
  • 2.11.1 Organon International Details
  • 2.11.2 Organon International Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Organon International SWOT Analysis
  • 2.11.4 Organon International Product and Services
  • 2.11.5 Organon International Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Afaxys
  • 2.12.1 Afaxys Details
  • 2.12.2 Afaxys Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Afaxys SWOT Analysis
  • 2.12.4 Afaxys Product and Services
  • 2.12.5 Afaxys Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Hormonal Contraceptive Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Hormonal Contraceptive Players Market Share
  • 3.2.2 Top 10 Hormonal Contraceptive Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Hormonal Contraceptive Revenue and Market Share by Regions
• 4.2 North America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 4.3 Europe Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 4.5 South America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

5 North America Hormonal Contraceptive Revenue by Countries

• 5.1 North America Hormonal Contraceptive Revenue by Countries (2015-2020)
• 5.2 USA Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 5.3 Canada Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

6 Europe Hormonal Contraceptive Revenue by Countries

• 6.1 Europe Hormonal Contraceptive Revenue by Countries (2015-2020)
• 6.2 Germany Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 6.3 UK Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 6.4 France Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 6.5 Russia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 6.6 Italy Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Hormonal Contraceptive Revenue by Countries

• 7.1 Asia-Pacific Hormonal Contraceptive Revenue by Countries (2015-2020)
• 7.2 China Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 7.3 Japan Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 7.4 Korea Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 7.5 India Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

8 South America Hormonal Contraceptive Revenue by Countries

• 8.1 South America Hormonal Contraceptive Revenue by Countries (2015-2020)
• 8.2 Brazil Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Hormonal Contraceptive by Countries

• 9.1 Middle East & Africa Hormonal Contraceptive Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 9.3 UAE Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Hormonal Contraceptive Revenue and Market Share by Type (2015-2020)
• 10.2 Global Hormonal Contraceptive Market Forecast by Type (2019-2024)
• 10.3 Oral Contraceptive Pills Revenue Growth Rate (2015-2025)
• 10.4 Injectable Birth Control Revenue Growth Rate (2015-2025)
• 10.5 Emergency Contraceptive Pills Revenue Growth Rate (2015-2025)
• 10.6 Vaginal Rings Revenue Growth Rate (2015-2025)
• 10.7 Transdermal Patches Revenue Growth Rate (2015-2025)

11 Global Hormonal Contraceptive Market Segment by Application

• 11.1 Global Hormonal Contraceptive Revenue Market Share by Application (2015-2020)
• 11.2 Hormonal Contraceptive Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2015-2020)
• 11.4 Household Revenue Growth (2015-2020)
• 11.5 Clinics Revenue Growth (2015-2020)

12 Global Hormonal Contraceptive Market Size Forecast (2021-2025)

• 12.1 Global Hormonal Contraceptive Market Size Forecast (2021-2025)
• 12.2 Global Hormonal Contraceptive Market Forecast by Regions (2021-2025)
• 12.3 North America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
• 12.4 Europe Hormonal Contraceptive Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Hormonal Contraceptive Revenue Market Forecast (2021-2025)
• 12.6 South America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Hormonal Contraceptive Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer